---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-052009"
form_type: "8-K"
ticker: "AIFC"
cik: "0000862861"
company_name: "AI Financial Corp"
filed_at: "2024-12-19T23:59:59+00:00"
generated_at: "2026-05-29T01:52:41.217404+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ALT5 Sigma to spin off healthcare assets into Alyea; LOI to acquire Soin Bioscience pain patch tech

## Summary
- All director nominees re-elected; CEO Peter Tassiopoulos elected to board for first time.
- Fintech platforms ALT5 Pay and Prime surpassed $2B in transaction volume in 2024.
- Spin-off of healthcare assets into Alyea Therapeutics planned for H1 2025 to unlock value.
- Alyea executed non-binding LOI to acquire Soin Bioscience's clear pain patch technology; market $4.8B, expected $7.33B by 2031.
- Alyea preparing pivotal trials for LDN for complex regional pain syndrome; FDA Orphan Drug designation granted.

## SEC filing metadata
- accession: 0001628280-24-052009
- form_type: 8-K
- ticker: AIFC
- cik: 0000862861
- company_name: AI Financial Corp
- filed_at: 2024-12-19T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/862861/000162828024052009/0001628280-24-052009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/862861/000162828024052009/jan-20241218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-052009
- JSON: https://secwatch.observer/filing/0001628280-24-052009.json
- Plain text: https://secwatch.observer/filing/0001628280-24-052009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.